These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12084593)

  • 1. Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease.
    Alber HF; Dulak J; Frick M; Dichtl W; Schwarzacher SP; Pachinger O; Weidinger F
    J Am Coll Cardiol; 2002 Jun; 39(12):1951-5. PubMed ID: 12084593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction.
    See VY; DeNofrio D; Goldberg L; Chang G; Sasseen B; Kolansky DM; Pickering F; Kao A; Loh E; Wilensky RL
    Am J Cardiol; 2003 Jul; 92(1):11-5. PubMed ID: 12842237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cholesterol synthesis/absorption markers and effects of cholesterol lowering by atorvastatin among patients with high risk of coronary heart disease.
    Qi Y; Liu J; Ma C; Wang W; Liu X; Wang M; Lv Q; Sun J; Liu J; Li Y; Zhao D
    J Lipid Res; 2013 Nov; 54(11):3189-97. PubMed ID: 23964121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JA; Seman LJ; Ferrari A; Rubenstein JJ
    Am J Cardiol; 2002 Oct; 90(7):689-96. PubMed ID: 12356379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins have biphasic effects on angiogenesis.
    Weis M; Heeschen C; Glassford AJ; Cooke JP
    Circulation; 2002 Feb; 105(6):739-45. PubMed ID: 11839631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels.
    Mercuro G; Zoncu S; Saiu F; Sarais C; Rosano GM
    Am J Cardiol; 2002 Oct; 90(7):747-50. PubMed ID: 12356389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease.
    Takahashi Y; Satoh M; Tabuchi T; Nakamura M
    Heart Vessels; 2012 Jul; 27(4):337-43. PubMed ID: 21643812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
    Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
    Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia.
    Wamhoff BR; Dixon JL; Sturek M
    J Vasc Res; 2002; 39(3):208-20. PubMed ID: 12097819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease.
    Yildiz A; Cakar MA; Baskurt M; Okcun B; Guzelsoy D; Coskun U
    Cardiovasc Ultrasound; 2007 Dec; 5():51. PubMed ID: 18163915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of combination therapy with amlodipine and atorvastatin on plasma adiponectin levels in hypertensive patients with coronary artery disease: combination therapy and adiponectin.
    Li M; Xu A; Lam KS; Cheung BM; Tse HF
    Postgrad Med; 2011 Nov; 123(6):66-71. PubMed ID: 22104455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells.
    Frick M; Dulak J; Cisowski J; Józkowicz A; Zwick R; Alber H; Dichtl W; Schwarzacher SP; Pachinger O; Weidinger F
    Atherosclerosis; 2003 Oct; 170(2):229-36. PubMed ID: 14612202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification.
    Sang ZC; Wang F; Zhou Q; Li YH; Li YG; Wang HP; Chen SY
    Chin Med J (Engl); 2009 Jul; 122(14):1615-20. PubMed ID: 19719960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin affects C-reactive protein levels in patients with coronary artery disease.
    Karaca I; Ilkay E; Akbulut M; Yavuzkir M; Pekdemir M; Akbulut H; Arslan N
    Curr Med Res Opin; 2003; 19(3):187-91. PubMed ID: 12803732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease.
    Hoshiga M; Arishiro K; Nakakoji T; Miyazaki N; Negoro N; Okabe T; Kohbayashi E; Ishihara T; Hanafusa T
    J Atheroscler Thromb; 2010 Jul; 17(7):705-11. PubMed ID: 20065610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.
    Vasa M; Fichtlscherer S; Adler K; Aicher A; Martin H; Zeiher AM; Dimmeler S
    Circulation; 2001 Jun; 103(24):2885-90. PubMed ID: 11413075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of MAP kinases in atorvastatin-induced VEGF release in cardiac myocytes.
    Nakajima K; Suga H; Matsuno H; Ishisaki A; Hirade K; Kozawa O
    Life Sci; 2006 Aug; 79(12):1214-20. PubMed ID: 16701707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.